Featured healthcare product

AJISTA

Escitalopram Oxalate in 5 mg and 10 mg tablets

AJISTA features Escitalopram Oxalate in 5 mg and 10 mg tablets, designed to support the management of depression and anxiety disorders with a clinically established SSRI profile.

The brochure highlights AJISTA as a proven anxiolytic and antidepressant option with greater efficacy than many other SSRIs, higher remission rates, low drug interaction potential, and improved sleep quality in patients with panic-related symptoms.

Product highlights

  • More efficacious than all other SSRIs
  • Higher remission rates than citralopram, sertraline, and venlafaxine
  • Significantly reduces relapse rates in depression and GAD
  • Low drug interaction
  • Improves subjective quality of sleep in female patients with panic disorders

Clinical focus

AJISTA is positioned for the treatment of depression and anxiety disorders, including panic-related symptoms, with emphasis on efficacy, patient adherence, and a favorable tolerability profile.

Key product details

Active ingredient: Escitalopram Oxalate
Strengths: 5 mg / 10 mg tablets
Use: Depression, anxiety disorders, and related symptom management under medical supervision.